Research & Development

R&D innovation is a core driver of SR BioPharma’s sustainable growth. With a long-standing focus on anti-HPV research and drug development, the company has built an integrated R&D team led by senior scientific experts and supported by a new generation of technical professionals, with capabilities spanning basic research, drug development, process scale-up, industrialization, and quality management. This has created a well-structured, multidisciplinary talent pipeline that combines complementary expertise with continuity across generations.

The team brings together senior scientists with extensive research experience in molecular virology, protein science, molecular pharmacology, and biopharmaceutical R&D. Its scientific leaders have research backgrounds at internationally recognized universities and research institutions, including the Chinese Academy of Sciences, the University of Tokyo, Tokyo University of Agriculture, the U.S. National Institutes of Health (NIH), the University of Cambridge, Northwestern University, George Washington University, and the University of California, San Francisco (UCSF). Their scientific expertise and experience provide sustained leadership for the advancement of the company’s core anti-HPV technologies and innovative product development.

Under the leadership of senior scientists, SR BioPharma has built a strong next-generation team spanning R&D, process development, scale-up, manufacturing, product registration, and quality management. Together, they form an integrated innovation system that advances scientific discoveries from research to product development and industrialization.